Key references: Treatment of tuberculous meningitis (TB meningitis)

  • Bourgi K, Fiske C, Sterling TR. Tuberculosis meningitis. Curr Infect Dis Rep 2017;19(11):39. https://www.ncbi.nlm.nih.gov/pubmed/28895024
  • Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013;13(1):27–35. https://www.ncbi.nlm.nih.gov/pubmed/23103177
  • Te Brake L, Dian S, Ganiem AR, Ruesen C, Burger D, Donders R, et al. Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis. Int J Antimicrob Agents 2015;45(5):496–503. https://www.ncbi.nlm.nih.gov/pubmed/25703312
  • Thwaites GE. Advances in the diagnosis and treatment of tuberculous meningitis. Curr Opin Neurol 2013;26(3):295–300. https://www.ncbi.nlm.nih.gov/pubmed/23493162